Cardiovascular Fitness and Venous Function in Trained and Untrained Subjects

The primary aim is to study the relationship between vascular function, cardiovascular fitness and age in healthy subjects. Individuals with the highest cardiovascular fitness will have the greatest arterial inflow independent of age.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Subjects

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Norwegian University of Science and Technology

Trondheim, 7491, Norway

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy subjects, 18-75 years of age

Exclusion criteria

Inability to exercise due to musculoskeletal conditions
Known ischemic cardiovascular disease
Smoking or tobacco use
Acute medical conditions
Active infections
Pharmacotherapy with known vascular effects

Treatment and study plan

Aerobic Interval training

Behavioral

One interval training session

Primary outcomes

Venous Compliance

Time frame: 2 weeks

Echocardiography; Test - retest

Secondary outcomes

Maximal oxygen uptake

Time frame: one test at baseline

Cardiopulmonary testing

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Registry information

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2012
First posted: Oct 6, 2010
Registry last updated: Feb 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed